Khwaja, Asim
Bjorkholm, Magnus
Gale, Rosemary E.
Levine, Ross L.
Jordan, Craig T.
Ehninger, Gerhard
Bloomfield, Clara D.
Estey, Eli
Burnett, Alan
Cornelissen, Jan J.
Scheinberg, David A.
Bouscary, Didier
Linch, David C.
Article History
First Online: 10 March 2016
Competing interests
: A.K. has received consulting fees from Celgene, Bergen Bio and research funding from AstraZeneca. G.E. has received research grants from Novartis and Celgene and has ownership in GEMoaB Monoclonals. A.B. receives salary from CTI Life Sciences Ltd. D.A.S. is the inventor of antibodies for AML owned by the Sloan Kettering Institute that are licensed to ‘for-profit companies’. D.C.L. has stock and receives salary from Autolus. All other authors declare no conflict of interests.